Global Electrophysiology Devices Market: Snapshot

The overall global electrophysiology devices market is characterized by robust competition. This is because of companies’ focus on cutting-edge research and development to build better products. They are also seen building synergies through strategic mergers and acquisitions and eyeing under-tapped markets of China and India.

Mainly serving to drive the global electrophysiology devices market is the rising cases of cardiovascular diseases. According to WHO, it is one of the leading causes of death in the world. Electrophysiology devices are basically cardiology specialty devices meant for diagnosis and treatment of cardiac arrhythmias and atrial fibrillation. A surge in the geriatric population worldwide, who are highly susceptible to cardiac diseases, and rising consumption of alcohol and smoking are expected to underpin global electrophysiology devices market in the near term.

Apart from the aforementioned factors, the global electrophysiology devices market is also likely to be boosted by the technological progress in the field leading to the launch of more evolved and effective products.

As per a report by Transparency Market Research, the global electrophysiology devices market is rising at a steady double digit CAGR.

Cardiovascular Disorders, Namely Ventricular Tachycardia, Mainly Fuelling Market

The global electrophysiology monitoring devices can be broadly segmented on the basis of products into electrophysiology monitoring devices and electrophysiology treatment devices. The electrophysiology monitoring devices are comprised of electrocorticograph (ECoG), electrocardiograph (ECG), electromyograph (EMG), electroencephalograph (EEG), electrooculograph (EOG), electroretinograph (ERG), x-ray systems, imaging and 3D mapping systems, diagnostic clectrophysiology catheters, and holter monitoring devices. The electrophysiology treatment devices, on the other hand, were categorized into pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy devices (CRT), and catheters. Further, the research report states that the increasing prevalence of cardiovascular disorders such as ventricular tachycardia and atrial fibrillation is the key factor fuelling the electrophysiology monitoring devices market substantially.

Numerous Key Players in North America, Fillips its Market

Geographically, the key segments of the global electrophysiology devices market are Asia Pacific, North America, Europe, and the Rest of the World. North America, among them, accounts for maximum share in the market. This is because of the presence of several key players in the region and state-of-the-art research and development facilities which has led to the proliferation of superior products in the region. The large elderly population and the growing prevalence of rhythmic cardiac disorders too have filliped the North America electrophysiology devices market. Europe trails North America with respect to market share because of the sizeable proportion of geriatric population and increasing instances of cardiovascular diseases.

Asia Pacific, on the other hand, is set to emerge as the most lucrative electrophysiology devices market. This is because the massive untapped opportunities owing to a developing medical and healthcare sector and higher instances of epilepsy, arrhythmias, and retinal disorders.

St. Jude Medical Inc., Siemens Healthcare, Abbott Laboratories, Boston Scientific, Biotronik SE & Co. KG., and GE Healthcare are to name a few of the key players in the global electrophysiology devices market.

Electrophysiology devices are used in the diagnosis and treatment of those diseases that occur due to abnormal electrical properties of biological cells and tissues. Electrophysiology devices have wide application in the management of cardiac arrhythmias. The study analyzes two major segments of the electrophysiology devices market namely, electrophysiology monitoring devices and treatment devices. The market for electrophysiology monitoring devices comprises for all those devices that are widely used in the diagnosis of atrial fibrillation, atrial flutter, ventricular tachycardia, epilepsy and retinal disorders. Electrophysiology monitoring devices are segmented as electrocardiograph, electroencephalograph, electroretinograph, electromyograph, electrocorticograph, electrooculograph, x-ray systems, imaging and 3D mapping systems, diagnostic electrophysiology catheters and Holter monitoring devices. The market for treatment devices includes pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy devices and catheters. The report also explains various technological advancements taking place in the segment.
 
The report includes market estimations of the global electrophysiology devices market in terms of value (USD million) for the period 2011 – 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global electrophysiology devices market. The report provides market size and forecasts for each segment, sub-segments and geographic region with CAGR in % for the period from 2013 to 2019.
 
The market is also forecasted in terms of value (USD million) for the period 2013 – 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the electrophysiology devices market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has also been discussed in the study that will help in decision making.
 
Some of the key market players of the global electrophysiology devices market include Boston Scientific, GE Healthcare, Medtronic, Inc., St. Jude Medical, Philips Healthcare and others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.
 
The global electrophysiology devices market is segmented into the following categories:
  • Electrophysiology Devices Market, by Segments
    • Electrophysiology Monitoring Devices Market, by Segments
      • Electrocardiograph (ECG)
      • Electroencephalograph (EEG)
      • Electrocorticograph (ECoG)
      • Electromyograph (EMG)
      • Electroretinograph (ERG)
      • Electrooculograph (EOG)
      • Holter Monitoring Devices
      • X-Ray Systems
      • Imaging and 3D Mapping Systems
      • Diagnostic Electrophysiology Catheters
    • Electrophysiology Treatment Devices Market, by Segments
      • Implantable Cardioverter Defibrillators (ICD’s)
      • Pacemaker
      • Cardiac Resynchronization Therapy Devices (CRT)
      • Catheters
  • Electrophysiology Devices Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)
.